Evoke Wealth LLC Has $567,000 Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Evoke Wealth LLC grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 40.4% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 1,087 shares of the medical equipment provider’s stock after buying an additional 313 shares during the period. Evoke Wealth LLC’s holdings in Intuitive Surgical were worth $567,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in ISRG. Atala Financial Inc acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth $25,000. Berbice Capital Management LLC acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth $26,000. BankPlus Trust Department acquired a new position in Intuitive Surgical in the fourth quarter valued at about $28,000. Kohmann Bosshard Financial Services LLC acquired a new position in Intuitive Surgical in the fourth quarter valued at about $31,000. Finally, MidAtlantic Capital Management Inc. acquired a new position in Intuitive Surgical in the third quarter valued at about $33,000. Institutional investors own 83.64% of the company’s stock.

Analyst Ratings Changes

ISRG has been the subject of a number of research analyst reports. CICC Research initiated coverage on Intuitive Surgical in a research note on Monday, January 27th. They issued a “neutral” rating and a $550.00 target price for the company. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Piper Sandler reissued an “overweight” rating and issued a $670.00 target price (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. BTIG Research boosted their target price on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. Finally, Raymond James upped their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $611.86.

Intuitive Surgical Stock Down 1.0 %

NASDAQ:ISRG opened at $483.95 on Wednesday. The stock’s 50 day moving average price is $565.43 and its two-hundred day moving average price is $531.90. The firm has a market capitalization of $172.37 billion, a price-to-earnings ratio of 75.50, a P/E/G ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Robert Desantis sold 11,545 shares of the stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares in the company, valued at approximately $2,607,925.28. This trade represents a 68.85 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock worth $17,691,621 over the last 90 days. Company insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.